nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—ABCC3—Conjugated Estrogens—osteoporosis	0.124	0.183	CbGbCtD
Gadoxetate—SLCO1B3—Conjugated Estrogens—osteoporosis	0.11	0.162	CbGbCtD
Gadoxetate—SLCO1B3—Estradiol—osteoporosis	0.097	0.142	CbGbCtD
Gadoxetate—ABCC4—Conjugated Estrogens—osteoporosis	0.095	0.139	CbGbCtD
Gadoxetate—ABCC2—Ethinyl Estradiol—osteoporosis	0.077	0.113	CbGbCtD
Gadoxetate—SLCO1B1—Conjugated Estrogens—osteoporosis	0.0643	0.0944	CbGbCtD
Gadoxetate—ABCC2—Conjugated Estrogens—osteoporosis	0.0565	0.083	CbGbCtD
Gadoxetate—SLCO1B1—Estradiol—osteoporosis	0.0565	0.0829	CbGbCtD
Gadoxetate—ABCC3—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00727	0.114	CbGpPWpGaD
Gadoxetate—ABCC4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00684	0.107	CbGpPWpGaD
Gadoxetate—ABCC2—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00577	0.0904	CbGpPWpGaD
Gadoxetate—SLCO1B1—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00542	0.0849	CbGpPWpGaD
Gadoxetate—SLCO1B3—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.00154	0.0241	CbGpPWpGaD
Gadoxetate—ABCC3—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.00139	0.0218	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—WDR1—osteoporosis	0.00137	0.0215	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—WDR1—osteoporosis	0.00131	0.0205	CbGpPWpGaD
Gadoxetate—ABCC3—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.00116	0.0182	CbGpPWpGaD
Gadoxetate—ABCC4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.00109	0.0171	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—CAP1—osteoporosis	0.00109	0.017	CbGpPWpGaD
Gadoxetate—SLCO1B1—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.00103	0.0162	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—CAP1—osteoporosis	0.00103	0.0162	CbGpPWpGaD
Gadoxetate—ABCC2—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000921	0.0144	CbGpPWpGaD
Gadoxetate—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000865	0.0136	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—PLEK—osteoporosis	0.000789	0.0124	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	0.000751	0.0118	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—TLN1—osteoporosis	0.00068	0.0107	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—VCL—osteoporosis	0.00067	0.0105	CbGpPWpGaD
Gadoxetate—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000667	0.0105	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	0.000647	0.0101	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	0.000639	0.01	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.000609	0.00954	CbGpPWpGaD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.000588	0.00921	CbGpPWpGaD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.000553	0.00866	CbGpPWpGaD
Gadoxetate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000529	0.00829	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—FGA—osteoporosis	0.000508	0.00796	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.000484	0.00759	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.000481	0.00754	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—FGB—osteoporosis	0.000462	0.00725	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.00044	0.0069	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.000382	0.00599	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—TNFRSF11B—osteoporosis	0.000359	0.00563	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—NFATC1—osteoporosis	0.000353	0.00554	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.00035	0.00548	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—WNT1—osteoporosis	0.000338	0.00529	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—WDR1—osteoporosis	0.000314	0.00492	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.000301	0.00472	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.000297	0.00466	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000294	0.00461	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000279	0.00437	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000266	0.00416	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000252	0.00395	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.000249	0.00389	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—CAP1—osteoporosis	0.000248	0.00389	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000225	0.00353	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000217	0.0034	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000212	0.00332	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—IGF1—osteoporosis	0.000209	0.00328	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000205	0.00321	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	0.000199	0.00313	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000198	0.0031	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—MGLL—osteoporosis	0.000197	0.00309	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000196	0.00307	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—AGER—osteoporosis	0.000195	0.00306	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000191	0.00299	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000188	0.00294	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000184	0.00288	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—AGER—osteoporosis	0.000183	0.00288	CbGpPWpGaD
Gadoxetate—Urticaria—Calcitriol—osteoporosis	0.000182	0.000714	CcSEcCtD
Gadoxetate—Palpitations—Zoledronate—osteoporosis	0.000181	0.000712	CcSEcCtD
Gadoxetate—Body temperature increased—Calcitriol—osteoporosis	0.000181	0.000711	CcSEcCtD
Gadoxetate—Abdominal pain—Calcitriol—osteoporosis	0.000181	0.000711	CcSEcCtD
Gadoxetate—Hypoaesthesia—Estradiol—osteoporosis	0.000181	0.000709	CcSEcCtD
Gadoxetate—Shock—Pamidronate—osteoporosis	0.00018	0.000708	CcSEcCtD
Gadoxetate—Loss of consciousness—Zoledronate—osteoporosis	0.00018	0.000708	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—ANXA2—osteoporosis	0.00018	0.00283	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PLEK—osteoporosis	0.00018	0.00283	CbGpPWpGaD
Gadoxetate—Hypersensitivity—Estropipate—osteoporosis	0.00018	0.000706	CcSEcCtD
Gadoxetate—Nervous system disorder—Pamidronate—osteoporosis	0.00018	0.000706	CcSEcCtD
Gadoxetate—Vomiting—Etidronic acid—osteoporosis	0.000179	0.000704	CcSEcCtD
Gadoxetate—Cough—Zoledronate—osteoporosis	0.000179	0.000703	CcSEcCtD
Gadoxetate—Tachycardia—Pamidronate—osteoporosis	0.000179	0.000702	CcSEcCtD
Gadoxetate—Connective tissue disorder—Estradiol—osteoporosis	0.000179	0.000701	CcSEcCtD
Gadoxetate—Rash—Etidronic acid—osteoporosis	0.000178	0.000698	CcSEcCtD
Gadoxetate—Convulsion—Zoledronate—osteoporosis	0.000178	0.000698	CcSEcCtD
Gadoxetate—Dermatitis—Etidronic acid—osteoporosis	0.000178	0.000697	CcSEcCtD
Gadoxetate—Vertigo—Conjugated Estrogens—osteoporosis	0.000178	0.000697	CcSEcCtD
Gadoxetate—Hyperhidrosis—Pamidronate—osteoporosis	0.000177	0.000696	CcSEcCtD
Gadoxetate—Syncope—Conjugated Estrogens—osteoporosis	0.000177	0.000695	CcSEcCtD
Gadoxetate—Hypersensitivity—Alendronate—osteoporosis	0.000177	0.000695	CcSEcCtD
Gadoxetate—Headache—Etidronic acid—osteoporosis	0.000177	0.000694	CcSEcCtD
Gadoxetate—Asthenia—Estropipate—osteoporosis	0.000175	0.000687	CcSEcCtD
Gadoxetate—Anorexia—Pamidronate—osteoporosis	0.000175	0.000686	CcSEcCtD
Gadoxetate—Chest pain—Zoledronate—osteoporosis	0.000175	0.000686	CcSEcCtD
Gadoxetate—Palpitations—Conjugated Estrogens—osteoporosis	0.000175	0.000685	CcSEcCtD
Gadoxetate—Anxiety—Zoledronate—osteoporosis	0.000174	0.000683	CcSEcCtD
Gadoxetate—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000174	0.000682	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000174	0.000681	CcSEcCtD
Gadoxetate—Paraesthesia—Risedronate—osteoporosis	0.000173	0.00068	CcSEcCtD
Gadoxetate—Pruritus—Estropipate—osteoporosis	0.000173	0.000678	CcSEcCtD
Gadoxetate—Discomfort—Zoledronate—osteoporosis	0.000173	0.000677	CcSEcCtD
Gadoxetate—Asthenia—Alendronate—osteoporosis	0.000172	0.000677	CcSEcCtD
Gadoxetate—Hypersensitivity—Ibandronate—osteoporosis	0.000172	0.000677	CcSEcCtD
Gadoxetate—Cough—Conjugated Estrogens—osteoporosis	0.000172	0.000677	CcSEcCtD
Gadoxetate—Dyspnoea—Risedronate—osteoporosis	0.000172	0.000675	CcSEcCtD
Gadoxetate—Hypotension—Pamidronate—osteoporosis	0.000171	0.000672	CcSEcCtD
Gadoxetate—Convulsion—Conjugated Estrogens—osteoporosis	0.000171	0.000672	CcSEcCtD
Gadoxetate—Dry mouth—Zoledronate—osteoporosis	0.000171	0.000671	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000171	0.00067	CcSEcCtD
Gadoxetate—Fatigue—Ethinyl Estradiol—osteoporosis	0.000171	0.000669	CcSEcCtD
Gadoxetate—Pruritus—Alendronate—osteoporosis	0.00017	0.000667	CcSEcCtD
Gadoxetate—Constipation—Ethinyl Estradiol—osteoporosis	0.000169	0.000664	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000169	0.00265	CbGpPWpGaD
Gadoxetate—Hypersensitivity—Calcitriol—osteoporosis	0.000169	0.000662	CcSEcCtD
Gadoxetate—Cardiac disorder—Estradiol—osteoporosis	0.000169	0.000662	CcSEcCtD
Gadoxetate—Flushing—Estradiol—osteoporosis	0.000169	0.000662	CcSEcCtD
Gadoxetate—Chest pain—Conjugated Estrogens—osteoporosis	0.000168	0.00066	CcSEcCtD
Gadoxetate—Asthenia—Ibandronate—osteoporosis	0.000168	0.000659	CcSEcCtD
Gadoxetate—Anxiety—Conjugated Estrogens—osteoporosis	0.000168	0.000658	CcSEcCtD
Gadoxetate—Nausea—Etidronic acid—osteoporosis	0.000168	0.000658	CcSEcCtD
Gadoxetate—Oedema—Zoledronate—osteoporosis	0.000168	0.000657	CcSEcCtD
Gadoxetate—Anaphylactic shock—Zoledronate—osteoporosis	0.000168	0.000657	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000167	0.000656	CcSEcCtD
Gadoxetate—Diarrhoea—Estropipate—osteoporosis	0.000167	0.000655	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Risedronate—osteoporosis	0.000167	0.000654	CcSEcCtD
Gadoxetate—Infection—Zoledronate—osteoporosis	0.000166	0.000653	CcSEcCtD
Gadoxetate—Fatigue—Risedronate—osteoporosis	0.000166	0.000653	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000166	0.0026	CbGpPWpGaD
Gadoxetate—Pruritus—Ibandronate—osteoporosis	0.000166	0.00065	CcSEcCtD
Gadoxetate—Constipation—Risedronate—osteoporosis	0.000165	0.000647	CcSEcCtD
Gadoxetate—Angiopathy—Estradiol—osteoporosis	0.000165	0.000647	CcSEcCtD
Gadoxetate—Shock—Zoledronate—osteoporosis	0.000165	0.000647	CcSEcCtD
Gadoxetate—Paraesthesia—Pamidronate—osteoporosis	0.000165	0.000646	CcSEcCtD
Gadoxetate—Diarrhoea—Alendronate—osteoporosis	0.000165	0.000645	CcSEcCtD
Gadoxetate—Asthenia—Calcitriol—osteoporosis	0.000164	0.000645	CcSEcCtD
Gadoxetate—Nervous system disorder—Zoledronate—osteoporosis	0.000164	0.000645	CcSEcCtD
Gadoxetate—Immune system disorder—Estradiol—osteoporosis	0.000164	0.000644	CcSEcCtD
Gadoxetate—Mediastinal disorder—Estradiol—osteoporosis	0.000164	0.000643	CcSEcCtD
Gadoxetate—Dyspnoea—Pamidronate—osteoporosis	0.000163	0.000642	CcSEcCtD
Gadoxetate—Tachycardia—Zoledronate—osteoporosis	0.000163	0.000642	CcSEcCtD
Gadoxetate—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000163	0.00064	CcSEcCtD
Gadoxetate—Chills—Estradiol—osteoporosis	0.000163	0.00064	CcSEcCtD
Gadoxetate—Skin disorder—Zoledronate—osteoporosis	0.000163	0.000638	CcSEcCtD
Gadoxetate—Pruritus—Calcitriol—osteoporosis	0.000162	0.000636	CcSEcCtD
Gadoxetate—Hyperhidrosis—Zoledronate—osteoporosis	0.000162	0.000635	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000162	0.000635	CcSEcCtD
Gadoxetate—Diarrhoea—Raloxifene—osteoporosis	0.000162	0.000635	CcSEcCtD
Gadoxetate—Dizziness—Estropipate—osteoporosis	0.000161	0.000633	CcSEcCtD
Gadoxetate—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000161	0.000633	CcSEcCtD
Gadoxetate—Oedema—Conjugated Estrogens—osteoporosis	0.000161	0.000633	CcSEcCtD
Gadoxetate—Infection—Conjugated Estrogens—osteoporosis	0.00016	0.000629	CcSEcCtD
Gadoxetate—Diarrhoea—Ibandronate—osteoporosis	0.00016	0.000628	CcSEcCtD
Gadoxetate—Anorexia—Zoledronate—osteoporosis	0.00016	0.000627	CcSEcCtD
Gadoxetate—Decreased appetite—Pamidronate—osteoporosis	0.000159	0.000626	CcSEcCtD
Gadoxetate—Dizziness—Alendronate—osteoporosis	0.000159	0.000624	CcSEcCtD
Gadoxetate—Shock—Conjugated Estrogens—osteoporosis	0.000159	0.000623	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000158	0.000621	CcSEcCtD
Gadoxetate—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000158	0.000621	CcSEcCtD
Gadoxetate—Fatigue—Pamidronate—osteoporosis	0.000158	0.00062	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Risedronate—osteoporosis	0.000158	0.000619	CcSEcCtD
Gadoxetate—Tachycardia—Conjugated Estrogens—osteoporosis	0.000157	0.000618	CcSEcCtD
Gadoxetate—Urticaria—Ethinyl Estradiol—osteoporosis	0.000157	0.000617	CcSEcCtD
Gadoxetate—Constipation—Pamidronate—osteoporosis	0.000157	0.000615	CcSEcCtD
Gadoxetate—Diarrhoea—Calcitriol—osteoporosis	0.000157	0.000615	CcSEcCtD
Gadoxetate—Skin disorder—Conjugated Estrogens—osteoporosis	0.000157	0.000615	CcSEcCtD
Gadoxetate—Hypotension—Zoledronate—osteoporosis	0.000157	0.000614	CcSEcCtD
Gadoxetate—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000156	0.000614	CcSEcCtD
Gadoxetate—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000156	0.000614	CcSEcCtD
Gadoxetate—Dizziness—Raloxifene—osteoporosis	0.000156	0.000614	CcSEcCtD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000156	0.00245	CbGpPWpGaD
Gadoxetate—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000156	0.000612	CcSEcCtD
Gadoxetate—Flatulence—Estradiol—osteoporosis	0.000156	0.000612	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—TLN1—osteoporosis	0.000155	0.00244	CbGpPWpGaD
Gadoxetate—Vomiting—Estropipate—osteoporosis	0.000155	0.000609	CcSEcCtD
Gadoxetate—Dysgeusia—Estradiol—osteoporosis	0.000155	0.000608	CcSEcCtD
Gadoxetate—Dizziness—Ibandronate—osteoporosis	0.000155	0.000607	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—AGER—osteoporosis	0.000155	0.00242	CbGpPWpGaD
Gadoxetate—Rash—Estropipate—osteoporosis	0.000154	0.000604	CcSEcCtD
Gadoxetate—Dermatitis—Estropipate—osteoporosis	0.000154	0.000603	CcSEcCtD
Gadoxetate—Anorexia—Conjugated Estrogens—osteoporosis	0.000154	0.000603	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—VCL—osteoporosis	0.000153	0.0024	CbGpPWpGaD
Gadoxetate—Urticaria—Risedronate—osteoporosis	0.000153	0.000601	CcSEcCtD
Gadoxetate—Back pain—Estradiol—osteoporosis	0.000153	0.0006	CcSEcCtD
Gadoxetate—Headache—Estropipate—osteoporosis	0.000153	0.0006	CcSEcCtD
Gadoxetate—Vomiting—Alendronate—osteoporosis	0.000153	0.0006	CcSEcCtD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000153	0.00239	CbGpPWpGaD
Gadoxetate—Abdominal pain—Risedronate—osteoporosis	0.000152	0.000598	CcSEcCtD
Gadoxetate—Body temperature increased—Risedronate—osteoporosis	0.000152	0.000598	CcSEcCtD
Gadoxetate—Rash—Alendronate—osteoporosis	0.000152	0.000595	CcSEcCtD
Gadoxetate—Dermatitis—Alendronate—osteoporosis	0.000151	0.000594	CcSEcCtD
Gadoxetate—Feeling abnormal—Pamidronate—osteoporosis	0.000151	0.000593	CcSEcCtD
Gadoxetate—Hypotension—Conjugated Estrogens—osteoporosis	0.000151	0.000591	CcSEcCtD
Gadoxetate—Headache—Alendronate—osteoporosis	0.000151	0.000591	CcSEcCtD
Gadoxetate—Paraesthesia—Zoledronate—osteoporosis	0.00015	0.00059	CcSEcCtD
Gadoxetate—Vomiting—Raloxifene—osteoporosis	0.00015	0.00059	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Pamidronate—osteoporosis	0.00015	0.000588	CcSEcCtD
Gadoxetate—Dyspnoea—Zoledronate—osteoporosis	0.000149	0.000586	CcSEcCtD
Gadoxetate—Rash—Raloxifene—osteoporosis	0.000149	0.000585	CcSEcCtD
Gadoxetate—Dermatitis—Raloxifene—osteoporosis	0.000149	0.000584	CcSEcCtD
Gadoxetate—Vomiting—Ibandronate—osteoporosis	0.000149	0.000584	CcSEcCtD
Gadoxetate—Tremor—Estradiol—osteoporosis	0.000148	0.000581	CcSEcCtD
Gadoxetate—Headache—Raloxifene—osteoporosis	0.000148	0.000581	CcSEcCtD
Gadoxetate—Rash—Ibandronate—osteoporosis	0.000148	0.000579	CcSEcCtD
Gadoxetate—Dermatitis—Ibandronate—osteoporosis	0.000147	0.000579	CcSEcCtD
Gadoxetate—Ill-defined disorder—Estradiol—osteoporosis	0.000147	0.000576	CcSEcCtD
Gadoxetate—Headache—Ibandronate—osteoporosis	0.000147	0.000575	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000146	0.00229	CbGpPWpGaD
Gadoxetate—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000146	0.000572	CcSEcCtD
Gadoxetate—Vomiting—Calcitriol—osteoporosis	0.000146	0.000572	CcSEcCtD
Gadoxetate—Decreased appetite—Zoledronate—osteoporosis	0.000146	0.000571	CcSEcCtD
Gadoxetate—Agitation—Estradiol—osteoporosis	0.000145	0.00057	CcSEcCtD
Gadoxetate—Nausea—Estropipate—osteoporosis	0.000145	0.000569	CcSEcCtD
Gadoxetate—Body temperature increased—Pamidronate—osteoporosis	0.000145	0.000569	CcSEcCtD
Gadoxetate—Abdominal pain—Pamidronate—osteoporosis	0.000145	0.000569	CcSEcCtD
Gadoxetate—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000145	0.000568	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000145	0.000567	CcSEcCtD
Gadoxetate—Rash—Calcitriol—osteoporosis	0.000144	0.000567	CcSEcCtD
Gadoxetate—Fatigue—Zoledronate—osteoporosis	0.000144	0.000567	CcSEcCtD
Gadoxetate—Dermatitis—Calcitriol—osteoporosis	0.000144	0.000566	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000144	0.00225	CbGpPWpGaD
Gadoxetate—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000144	0.000564	CcSEcCtD
Gadoxetate—Headache—Calcitriol—osteoporosis	0.000144	0.000563	CcSEcCtD
Gadoxetate—Constipation—Zoledronate—osteoporosis	0.000143	0.000562	CcSEcCtD
Gadoxetate—Nausea—Alendronate—osteoporosis	0.000143	0.00056	CcSEcCtD
Gadoxetate—Malaise—Estradiol—osteoporosis	0.000143	0.00056	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000142	0.00223	CbGpPWpGaD
Gadoxetate—Hypersensitivity—Risedronate—osteoporosis	0.000142	0.000558	CcSEcCtD
Gadoxetate—Vertigo—Estradiol—osteoporosis	0.000142	0.000558	CcSEcCtD
Gadoxetate—Asthenia—Ethinyl Estradiol—osteoporosis	0.000142	0.000557	CcSEcCtD
Gadoxetate—Syncope—Estradiol—osteoporosis	0.000142	0.000557	CcSEcCtD
Gadoxetate—Nausea—Raloxifene—osteoporosis	0.00014	0.000551	CcSEcCtD
Gadoxetate—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00014	0.00055	CcSEcCtD
Gadoxetate—Pruritus—Ethinyl Estradiol—osteoporosis	0.00014	0.000549	CcSEcCtD
Gadoxetate—Palpitations—Estradiol—osteoporosis	0.00014	0.000548	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000139	0.000546	CcSEcCtD
Gadoxetate—Fatigue—Conjugated Estrogens—osteoporosis	0.000139	0.000546	CcSEcCtD
Gadoxetate—Nausea—Ibandronate—osteoporosis	0.000139	0.000546	CcSEcCtD
Gadoxetate—Loss of consciousness—Estradiol—osteoporosis	0.000139	0.000546	CcSEcCtD
Gadoxetate—Asthenia—Risedronate—osteoporosis	0.000138	0.000543	CcSEcCtD
Gadoxetate—Feeling abnormal—Zoledronate—osteoporosis	0.000138	0.000542	CcSEcCtD
Gadoxetate—Cough—Estradiol—osteoporosis	0.000138	0.000542	CcSEcCtD
Gadoxetate—Constipation—Conjugated Estrogens—osteoporosis	0.000138	0.000541	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Zoledronate—osteoporosis	0.000137	0.000537	CcSEcCtD
Gadoxetate—Pruritus—Risedronate—osteoporosis	0.000136	0.000536	CcSEcCtD
Gadoxetate—Nausea—Calcitriol—osteoporosis	0.000136	0.000534	CcSEcCtD
Gadoxetate—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000135	0.000531	CcSEcCtD
Gadoxetate—Hypersensitivity—Pamidronate—osteoporosis	0.000135	0.00053	CcSEcCtD
Gadoxetate—Chest pain—Estradiol—osteoporosis	0.000135	0.000528	CcSEcCtD
Gadoxetate—Anxiety—Estradiol—osteoporosis	0.000134	0.000527	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000134	0.000525	CcSEcCtD
Gadoxetate—Urticaria—Zoledronate—osteoporosis	0.000133	0.000522	CcSEcCtD
Gadoxetate—Discomfort—Estradiol—osteoporosis	0.000133	0.000522	CcSEcCtD
Gadoxetate—Abdominal pain—Zoledronate—osteoporosis	0.000132	0.00052	CcSEcCtD
Gadoxetate—Body temperature increased—Zoledronate—osteoporosis	0.000132	0.00052	CcSEcCtD
Gadoxetate—Diarrhoea—Risedronate—osteoporosis	0.000132	0.000518	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000132	0.000518	CcSEcCtD
Gadoxetate—Dry mouth—Estradiol—osteoporosis	0.000132	0.000517	CcSEcCtD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000132	0.00206	CbGpPWpGaD
Gadoxetate—Asthenia—Pamidronate—osteoporosis	0.000132	0.000516	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—PKM—osteoporosis	0.000131	0.00206	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—FDPS—osteoporosis	0.000131	0.00206	CbGpPWpGaD
Gadoxetate—Dizziness—Ethinyl Estradiol—osteoporosis	0.000131	0.000513	CcSEcCtD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.00013	0.00203	CbGpPWpGaD
Gadoxetate—Pruritus—Pamidronate—osteoporosis	0.00013	0.000509	CcSEcCtD
Gadoxetate—Oedema—Estradiol—osteoporosis	0.000129	0.000507	CcSEcCtD
Gadoxetate—Anaphylactic shock—Estradiol—osteoporosis	0.000129	0.000507	CcSEcCtD
Gadoxetate—Infection—Estradiol—osteoporosis	0.000128	0.000503	CcSEcCtD
Gadoxetate—Urticaria—Conjugated Estrogens—osteoporosis	0.000128	0.000503	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—RAP1A—osteoporosis	0.000128	0.00201	CbGpPWpGaD
Gadoxetate—Dizziness—Risedronate—osteoporosis	0.000128	0.000501	CcSEcCtD
Gadoxetate—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000128	0.0005	CcSEcCtD
Gadoxetate—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000128	0.0005	CcSEcCtD
Gadoxetate—Shock—Estradiol—osteoporosis	0.000127	0.000498	CcSEcCtD
Gadoxetate—Nervous system disorder—Estradiol—osteoporosis	0.000127	0.000497	CcSEcCtD
Gadoxetate—Tachycardia—Estradiol—osteoporosis	0.000126	0.000494	CcSEcCtD
Gadoxetate—Vomiting—Ethinyl Estradiol—osteoporosis	0.000126	0.000494	CcSEcCtD
Gadoxetate—ABCC4—Platelet degranulation—TGFB1—osteoporosis	0.000125	0.00197	CbGpPWpGaD
Gadoxetate—Diarrhoea—Pamidronate—osteoporosis	0.000125	0.000492	CcSEcCtD
Gadoxetate—Skin disorder—Estradiol—osteoporosis	0.000125	0.000492	CcSEcCtD
Gadoxetate—Hyperhidrosis—Estradiol—osteoporosis	0.000125	0.00049	CcSEcCtD
Gadoxetate—Rash—Ethinyl Estradiol—osteoporosis	0.000125	0.00049	CcSEcCtD
Gadoxetate—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000125	0.000489	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—PGLS—osteoporosis	0.000124	0.00195	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GPD2—osteoporosis	0.000124	0.00195	CbGpPWpGaD
Gadoxetate—Headache—Ethinyl Estradiol—osteoporosis	0.000124	0.000486	CcSEcCtD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000124	0.00194	CbGpPWpGaD
Gadoxetate—Hypersensitivity—Zoledronate—osteoporosis	0.000123	0.000484	CcSEcCtD
Gadoxetate—Vomiting—Risedronate—osteoporosis	0.000123	0.000481	CcSEcCtD
Gadoxetate—Rash—Risedronate—osteoporosis	0.000122	0.000477	CcSEcCtD
Gadoxetate—Dermatitis—Risedronate—osteoporosis	0.000122	0.000477	CcSEcCtD
Gadoxetate—Dizziness—Pamidronate—osteoporosis	0.000121	0.000476	CcSEcCtD
Gadoxetate—Headache—Risedronate—osteoporosis	0.000121	0.000474	CcSEcCtD
Gadoxetate—Asthenia—Zoledronate—osteoporosis	0.00012	0.000472	CcSEcCtD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	0.00012	0.00187	CbGpPWpGaD
Gadoxetate—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000119	0.000466	CcSEcCtD
Gadoxetate—Pruritus—Zoledronate—osteoporosis	0.000119	0.000465	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—PKM—osteoporosis	0.000118	0.00185	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—FDPS—osteoporosis	0.000118	0.00185	CbGpPWpGaD
Gadoxetate—Nausea—Ethinyl Estradiol—osteoporosis	0.000118	0.000461	CcSEcCtD
Gadoxetate—Vomiting—Pamidronate—osteoporosis	0.000117	0.000458	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—FGA—osteoporosis	0.000116	0.00182	CbGpPWpGaD
Gadoxetate—Paraesthesia—Estradiol—osteoporosis	0.000116	0.000455	CcSEcCtD
Gadoxetate—Asthenia—Conjugated Estrogens—osteoporosis	0.000116	0.000454	CcSEcCtD
Gadoxetate—Rash—Pamidronate—osteoporosis	0.000116	0.000454	CcSEcCtD
Gadoxetate—Dermatitis—Pamidronate—osteoporosis	0.000116	0.000453	CcSEcCtD
Gadoxetate—Dyspnoea—Estradiol—osteoporosis	0.000115	0.000452	CcSEcCtD
Gadoxetate—Headache—Pamidronate—osteoporosis	0.000115	0.000451	CcSEcCtD
Gadoxetate—Diarrhoea—Zoledronate—osteoporosis	0.000115	0.00045	CcSEcCtD
Gadoxetate—Nausea—Risedronate—osteoporosis	0.000115	0.00045	CcSEcCtD
Gadoxetate—Pruritus—Conjugated Estrogens—osteoporosis	0.000114	0.000448	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—ATIC—osteoporosis	0.000114	0.00178	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PNP—osteoporosis	0.000114	0.00178	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000114	0.00178	CbGpPWpGaD
Gadoxetate—Decreased appetite—Estradiol—osteoporosis	0.000112	0.00044	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—GPD2—osteoporosis	0.000112	0.00176	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PGLS—osteoporosis	0.000112	0.00176	CbGpPWpGaD
Gadoxetate—Gastrointestinal disorder—Estradiol—osteoporosis	0.000111	0.000437	CcSEcCtD
Gadoxetate—Fatigue—Estradiol—osteoporosis	0.000111	0.000437	CcSEcCtD
Gadoxetate—Dizziness—Zoledronate—osteoporosis	0.000111	0.000435	CcSEcCtD
Gadoxetate—Constipation—Estradiol—osteoporosis	0.00011	0.000433	CcSEcCtD
Gadoxetate—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00011	0.000433	CcSEcCtD
Gadoxetate—Nausea—Pamidronate—osteoporosis	0.000109	0.000427	CcSEcCtD
Gadoxetate—Dizziness—Conjugated Estrogens—osteoporosis	0.000107	0.000419	CcSEcCtD
Gadoxetate—Vomiting—Zoledronate—osteoporosis	0.000107	0.000418	CcSEcCtD
Gadoxetate—Feeling abnormal—Estradiol—osteoporosis	0.000106	0.000417	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—FGB—osteoporosis	0.000106	0.00166	CbGpPWpGaD
Gadoxetate—Rash—Zoledronate—osteoporosis	0.000106	0.000414	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Estradiol—osteoporosis	0.000106	0.000414	CcSEcCtD
Gadoxetate—Dermatitis—Zoledronate—osteoporosis	0.000106	0.000414	CcSEcCtD
Gadoxetate—Headache—Zoledronate—osteoporosis	0.000105	0.000412	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—PNP—osteoporosis	0.000103	0.00161	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ATIC—osteoporosis	0.000103	0.00161	CbGpPWpGaD
Gadoxetate—Vomiting—Conjugated Estrogens—osteoporosis	0.000103	0.000402	CcSEcCtD
Gadoxetate—Urticaria—Estradiol—osteoporosis	0.000103	0.000402	CcSEcCtD
Gadoxetate—Body temperature increased—Estradiol—osteoporosis	0.000102	0.0004	CcSEcCtD
Gadoxetate—Abdominal pain—Estradiol—osteoporosis	0.000102	0.0004	CcSEcCtD
Gadoxetate—Rash—Conjugated Estrogens—osteoporosis	0.000102	0.000399	CcSEcCtD
Gadoxetate—Dermatitis—Conjugated Estrogens—osteoporosis	0.000102	0.000399	CcSEcCtD
Gadoxetate—Headache—Conjugated Estrogens—osteoporosis	0.000101	0.000396	CcSEcCtD
Gadoxetate—Nausea—Zoledronate—osteoporosis	9.95e-05	0.00039	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—CA2—osteoporosis	9.67e-05	0.00152	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—OXCT1—osteoporosis	9.67e-05	0.00152	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	9.66e-05	0.00151	CbGpPWpGaD
Gadoxetate—Nausea—Conjugated Estrogens—osteoporosis	9.58e-05	0.000376	CcSEcCtD
Gadoxetate—Hypersensitivity—Estradiol—osteoporosis	9.51e-05	0.000373	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—MGLL—osteoporosis	9.42e-05	0.00148	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—IGF1—osteoporosis	9.28e-05	0.00146	CbGpPWpGaD
Gadoxetate—Asthenia—Estradiol—osteoporosis	9.26e-05	0.000363	CcSEcCtD
Gadoxetate—Pruritus—Estradiol—osteoporosis	9.13e-05	0.000358	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	8.88e-05	0.00139	CbGpPWpGaD
Gadoxetate—Diarrhoea—Estradiol—osteoporosis	8.83e-05	0.000347	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—FDPS—osteoporosis	8.81e-05	0.00138	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PKM—osteoporosis	8.81e-05	0.00138	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—OXCT1—osteoporosis	8.72e-05	0.00137	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CA2—osteoporosis	8.72e-05	0.00137	CbGpPWpGaD
Gadoxetate—Dizziness—Estradiol—osteoporosis	8.54e-05	0.000335	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—MGLL—osteoporosis	8.5e-05	0.00133	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GPD2—osteoporosis	8.35e-05	0.00131	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PGLS—osteoporosis	8.35e-05	0.00131	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—TGFB1—osteoporosis	8.25e-05	0.00129	CbGpPWpGaD
Gadoxetate—Vomiting—Estradiol—osteoporosis	8.21e-05	0.000322	CcSEcCtD
Gadoxetate—Rash—Estradiol—osteoporosis	8.14e-05	0.000319	CcSEcCtD
Gadoxetate—ABCC4—Ectoderm Differentiation—MYC—osteoporosis	8.13e-05	0.00127	CbGpPWpGaD
Gadoxetate—Dermatitis—Estradiol—osteoporosis	8.13e-05	0.000319	CcSEcCtD
Gadoxetate—Headache—Estradiol—osteoporosis	8.09e-05	0.000317	CcSEcCtD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	8.02e-05	0.00126	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—IDH2—osteoporosis	8.01e-05	0.00126	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—TGFB1—osteoporosis	7.75e-05	0.00122	CbGpPWpGaD
Gadoxetate—Nausea—Estradiol—osteoporosis	7.67e-05	0.000301	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—ATIC—osteoporosis	7.64e-05	0.0012	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PNP—osteoporosis	7.64e-05	0.0012	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP27A1—osteoporosis	7.53e-05	0.00118	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ACP5—osteoporosis	7.33e-05	0.00115	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	7.23e-05	0.00113	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—IDH2—osteoporosis	7.23e-05	0.00113	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.9e-05	0.00108	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—TPI1—osteoporosis	6.81e-05	0.00107	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP27A1—osteoporosis	6.8e-05	0.00107	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ACP5—osteoporosis	6.61e-05	0.00104	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—TGFB1—osteoporosis	6.54e-05	0.00102	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.53e-05	0.00102	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CA2—osteoporosis	6.5e-05	0.00102	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—OXCT1—osteoporosis	6.5e-05	0.00102	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—P4HB—osteoporosis	6.4e-05	0.001	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—MGLL—osteoporosis	6.33e-05	0.000992	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GAPDH—osteoporosis	6.29e-05	0.000985	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.23e-05	0.000976	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—TPI1—osteoporosis	6.15e-05	0.000963	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—RAP1A—osteoporosis	6.12e-05	0.00096	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.97e-05	0.000935	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.86e-05	0.000918	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—P4HB—osteoporosis	5.78e-05	0.000906	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GAPDH—osteoporosis	5.67e-05	0.000889	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	5.57e-05	0.000872	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—RAP1A—osteoporosis	5.52e-05	0.000866	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—IDH2—osteoporosis	5.38e-05	0.000844	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.34e-05	0.000837	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP27A1—osteoporosis	5.06e-05	0.000793	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ENO1—osteoporosis	4.95e-05	0.000776	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.94e-05	0.000774	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ACP5—osteoporosis	4.92e-05	0.000772	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PSMA2—osteoporosis	4.88e-05	0.000764	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PSMA5—osteoporosis	4.88e-05	0.000764	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.86e-05	0.000762	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.82e-05	0.000755	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IGF1—osteoporosis	4.79e-05	0.00075	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.64e-05	0.000727	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—TPI1—osteoporosis	4.58e-05	0.000717	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ENO1—osteoporosis	4.47e-05	0.0007	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PSMA2—osteoporosis	4.4e-05	0.00069	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PSMA5—osteoporosis	4.4e-05	0.00069	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—P4HB—osteoporosis	4.3e-05	0.000674	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GAPDH—osteoporosis	4.22e-05	0.000662	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—RAP1A—osteoporosis	4.11e-05	0.000645	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP19A1—osteoporosis	3.96e-05	0.00062	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.59e-05	0.000562	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP19A1—osteoporosis	3.57e-05	0.000559	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ENO1—osteoporosis	3.33e-05	0.000521	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PSMA2—osteoporosis	3.28e-05	0.000514	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PSMA5—osteoporosis	3.28e-05	0.000514	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ADCY5—osteoporosis	3.23e-05	0.000507	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GPX1—osteoporosis	3.22e-05	0.000505	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—MTHFR—osteoporosis	2.97e-05	0.000466	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ADCY5—osteoporosis	2.92e-05	0.000457	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GPX1—osteoporosis	2.91e-05	0.000456	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TGFB1—osteoporosis	2.87e-05	0.00045	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—MTHFR—osteoporosis	2.68e-05	0.00042	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP19A1—osteoporosis	2.66e-05	0.000417	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—POMC—osteoporosis	2.38e-05	0.000373	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ADCY5—osteoporosis	2.17e-05	0.00034	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GPX1—osteoporosis	2.16e-05	0.000339	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—POMC—osteoporosis	2.15e-05	0.000336	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—MTHFR—osteoporosis	2e-05	0.000313	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—POMC—osteoporosis	1.6e-05	0.00025	CbGpPWpGaD
